PT  - JOURNAL ARTICLE
AU  - Honeyford, K
AU  - Coughlan, C
AU  - Nijman, R
AU  - Expert, P
AU  - Burcea, G
AU  - Maconochie, I
AU  - Kinderlerer, A
AU  - Cooke, G S
AU  - Costelloe, C E
TI  - Changes in Emergency Department attendances before and after COVID-19 lockdown implementation: a cross sectional study of one urban NHS Hospital Trust
AID  - 10.1101/2020.07.20.20157560
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.20.20157560
4099  - http://medrxiv.org/content/early/2020/07/21/2020.07.20.20157560.short
4100  - http://medrxiv.org/content/early/2020/07/21/2020.07.20.20157560.full
AB  - Background Emergency Department (ED) attendances have fallen across the UK since the ‘lockdown’ introduced on 23rd March 2020 to limit the spread of coronavirus disease 2019 (COVID-19). We hypothesised that reductions would vary by patient age and disease type. We examined pre- and in-lockdown ED attendances for two COVID-19 unrelated diagnoses; one likely to be affected by lockdown measures (gastroenteritis) and one likely to be unaffected (appendicitis).Methods Retrospective cross-sectional study conducted across two EDs in one London hospital Trust. We compared all adult and paediatric ED attendances, before (January 2020) and during lockdown (March/April 2020). Key patient demographics, method of arrival and discharge location were compared. We used SNOMED codes to define attendances for gastroenteritis and appendicitis.Results ED attendances fell from 1129 per day before lockdown to 584 in-lockdown; 51.7% of pre-lockdown rates. In-lockdown attendances were lowest for under-18s (16.0% of pre-lockdown). The proportion of patients admitted to hospital increased from 17.3% to 24.0% and the proportion admitted to intensive care increased four-fold. Attendances for gastroenteritis fell from 511 to 103; 20.2% of pre-lockdown rates. Attendances for appendicitis also decreased, from 144 to 41; 28.5% of pre-lockdown rates.Conclusion ED attendances fell substantially following lockdown implementation. The biggest reduction was for under-18s. We observed reductions in attendances for gastroenteritis and appendicitis. This may reflect lower rates of infectious disease transmission, though the fall in appendicitis-related attendances suggests that behavioural factors are also important. Larger studies are urgently needed to understand changing patterns of ED use and access to emergency care during the COVID-19 pandemic.What this paper addsWhat is already known on this subject:ED attendances have decreased during the COVID-19 associated lockdown.Various theories have been suggested for changes in ED attendance, including lower transmission of infectious diseases and patients heeding recommendations from government bodies.What this study adds:Reductions in ED attendances vary by age group and disease type.We propose a conceptual casual framework for underlying reasons behind changes in ED attendance in England during the COVID-19 lockdown.Following lockdown implementation, we observed a reduction in ED attendances with both infectious and non-infectious diseases. This suggests that reduced transmission of infectious disease is not the only cause of lower overall ED attendances.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis report is independent research funded by the UK National Institute for Health Research (NIHR) Biomedical Research Centre NIHR-BRC-P68711. KH and PE are supported by the NIHR Imperial Biomedical Research Centre (BRC). CC is supported by a personal NIHR Career Development Fellowship (NIHR-2016-090-015). GSC is supported by NIHR Research Professorship. RGN is supported by NIHR academic clinical lecturer award (ACL-2018-21-007). ChC's work as a Clinical Research Fellow in Integrated Care is supported by a grant from the Imperial Health Charity. This research was funded by the NIHR Imperial Biomedical Research Centre (BRC). The research was conducted using National Institute of Health Research Health Informatics Collaborative data resources. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. Imperial College London is grateful for support from the NW London NIHR Applied Research Collaboration. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics for this study was granted service evaluation approval through Imperial College London NHS Trust (Ref:228)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available through: The Imperial College Healthcare NHS Trust (ICHT) Clinical Analysis, Research and Evaluation (iCARE) platform. Requests to access ICHNT and NWL's WSIC COVID-19 de-identified datasets on iCARE are reviewed and approved by the COVID-19 NWL Data Prioritisation Group. This group meets weekly to review both operational and research related requests to access the de-identified data for COVID-19 related projects and is chaired by the Sector wide Caldicott guardian. The COVID-19 Data Prioritisation Group also maintains oversight of dataset development and ensures clinical oversight of all research. To be allowed access, a researcher must be sponsored by a senior clinician practicing at one of the relevant data controllers. https://imperialcollegehealthpartners.com/covid-19-data-prioritisation-group/